"Prognosis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations.
| Descriptor ID |
D011379
|
| MeSH Number(s) |
E01.789
|
| Concept/Terms |
Prognostic Factors- Prognostic Factors
- Factor, Prognostic
- Factors, Prognostic
- Prognostic Factor
|
Below are MeSH descriptors whose meaning is more general than "Prognosis".
- Analytical, Diagnostic and Therapeutic Techniques and Equipment [E]
- Diagnosis [E01]
- Prognosis [E01.789]
Below are MeSH descriptors whose meaning is more specific than "Prognosis".
This graph shows the total number of publications written about "Prognosis" by people in this website by year, and whether "Prognosis" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 0 | 22 | 22 |
| 1997 | 0 | 27 | 27 |
| 1998 | 0 | 33 | 33 |
| 1999 | 0 | 29 | 29 |
| 2000 | 0 | 46 | 46 |
| 2001 | 0 | 36 | 36 |
| 2002 | 0 | 36 | 36 |
| 2003 | 0 | 53 | 53 |
| 2004 | 0 | 53 | 53 |
| 2005 | 0 | 58 | 58 |
| 2006 | 0 | 72 | 72 |
| 2007 | 0 | 88 | 88 |
| 2008 | 0 | 84 | 84 |
| 2009 | 0 | 104 | 104 |
| 2010 | 0 | 107 | 107 |
| 2011 | 0 | 123 | 123 |
| 2012 | 0 | 106 | 106 |
| 2013 | 2 | 141 | 143 |
| 2014 | 1 | 170 | 171 |
| 2015 | 0 | 176 | 176 |
| 2016 | 5 | 157 | 162 |
| 2017 | 3 | 197 | 200 |
| 2018 | 1 | 227 | 228 |
| 2019 | 1 | 231 | 232 |
| 2020 | 0 | 222 | 222 |
| 2021 | 1 | 141 | 142 |
| 2022 | 0 | 70 | 70 |
| 2023 | 0 | 95 | 95 |
| 2024 | 0 | 134 | 134 |
| 2025 | 0 | 110 | 110 |
| 2026 | 0 | 12 | 12 |
To return to the timeline,
click here.
Below are the most recent publications written about "Prognosis" by people in Profiles.
-
POD24 is a novel determinant of prognosis in patients with Waldenstr?m macroglobulinemia. Blood Adv. 2026 Apr 14; 10(7):2322-2327.
-
Clinical Course and Impact of Breaks in Therapy for Children With Relapsed/Refractory Solid Tumors. Pediatr Blood Cancer. 2026 May; 73(5):e70199.
-
Efficacy and Tolerability of Topotecan/Cyclophosphamide/Dinutuximab in Relapsed and Refractory High-Risk Neuroblastoma: A Multi-Institutional Retrospective Study. Pediatr Blood Cancer. 2026 May; 73(5):e70195.
-
Children and Young People With First Relapse or Progression of Upfront Metastatic Rhabdomyosarcoma: An Analysis of Clinical Features and Outcomes From the INternational Soft Tissue saRcoma ConsorTium (INSTRuCT). Cancer Med. 2026 Mar; 15(3):e71524.
-
Host- and pathogen-related determinants of pulmonary versus extrapulmonary tuberculosis. Eur Respir Rev. 2026 01; 35(179).
-
Clinical outcomes in MetALD compared with ALD in patients referred for liver transplant evaluation. Hepatol Commun. 2026 Feb 01; 10(2).
-
New comorbidity index associated with survival after chimeric antigen receptor T-cell therapy for large B-cell lymphoma. Blood Adv. 2026 Jan 13; 10(1):217-227.
-
Sequential Combination of Unfavorable Histology, Followed by Clinical Stage M, Defines High-Risk Neuroblastoma: A Report from the Children's Oncology Group. Clin Cancer Res. 2026 Jan 06; 32(1):127-134.
-
Parent-to-Child Information Disclosure in Pediatric Oncology. Pediatr Blood Cancer. 2026 Mar; 73(3):e70098.
-
Advances in the Basic Sciences in Thoracic Oncology in the Last 20 Years and Their Translational Impact. J Thorac Oncol. 2026 Jan; 21(1):41-76.